Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer - EBioMedicine
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma | PNAS
Therapeutic Implications of Molecular Subtyping for Pancreatic Cancer
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy
Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions - The American Journal of Pathology
Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes | Scientific Reports
Pancreatic Ductal Deletion of Hnf1b Disrupts Exocrine Homeostasis, Leads to Pancreatitis, and Facilitates Tumorigenesis - Cellular and Molecular Gastroenterology and Hepatology
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
Molecular subtypes of pancreatic cancer | Nature Reviews Gastroenterology & Hepatology
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Cancers | Free Full-Text | Mucins and Pancreatic Cancer | HTML
Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatics Analysis and Molecular Docking Experiments | medRxiv
Oncotarget: Prognostic and predictive factors | EurekAlert!
Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
Proteogenomic characterization of pancreatic ductal adenocarcinoma - ScienceDirect
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma - ScienceDirect
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | SpringerLink
IJMS | Free Full-Text | Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance? | HTML
Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications - Annals of Oncology
Progression model of pancreatic ductal adenocarcinoma from normal... | Download Scientific Diagram
![PDF] Role of emerging molecular markers in pancreatic cyst fluid | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/49d57c9033835d9702cf336428550607519129e9/3-Table1-1.png "PDF] Role of emerging molecular markers in pancreatic cyst fluid | Semantic Scholar")
PDF] Role of emerging molecular markers in pancreatic cyst fluid | Semantic Scholar
Frontiers | Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment | Immunology
Carcinogenesis of Pancreatic Ductal Adenocarcinoma - Gastroenterology
Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging | eLife
Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinoma
Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features - Gastroenterology
